Article info
Clinical and epidemiological research
Extended report
Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review
- Correspondence to J J Luime, Erasmus Medical Center, Department of Rheumatology, PO Box 2040, 3000 CA, Rotterdam, The Netherlands; j.luime{at}erasmusmc.nl
Citation
Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review
Publication history
- Accepted March 3, 2009
- First published March 15, 2009.
Online issue publication
November 02, 2019
Article Versions
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.